Aratana Therapeutics

company

About

Aratana Therapeutics develops innovative therapies for the animal health industry.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$12M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
51 - 100
Operating Status
Active

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$12M
Aratana Therapeutics has raised a total of $12M in funding over 2 rounds. Their latest funding was raised on Jan 31, 2013 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 31, 2013 Series C $12M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Aratana Therapeutics is funded by 2 investors. Midwest Venture Alliance and Women's Capital Connection are the most recent investors.
Investor Name Lead Investor Funding Round
Midwest Venture Alliance Series C
Women's Capital Connection Series C